Paradigm Biopharmaceuticals initiates voluntary administration process

Paradigm Biopharmaceuticals Ltd said its board has initiated a voluntary administration process and plans to develop a proposal for a deed of company arrangement, with securities remaining suspended on the ASX during administration.